Resultados de búsqueda - E. V. Artamonova

GENERAL PRINCIPLES OF DRUG TREATMENT FOR PRIMARY OPERABLE AND LOCALLY ADVANCED BREAST CANCER por E. V. Artamonova

Connect to this object online.

PALBOCICLIB IN COMBINATION WITH HORMONE THERAPY FOR LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER: NEW HIGHLY EFFECTIVE STRATEGY OF DRUG TREATMENT por E. V. Artamonova

Connect to this object online.

PRACTICAL ASPECTS OF ADMINISTERING CYCLIN-DEPENDENT KINASES INHIBITORS: EFFICACY AND TOLERABILITY por E. V. Artamonova

Connect to this object online.

Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer por E. V. Artamonova

Connect to this object online.

Drug treatment for cancer of the corpus uteri: Protracted stagnation or breakthrough expectation por E. V. Artamonova

Connect to this object online.

Drug treatment for metastatic breast cancer por E. V. Artamonova

Connect to this object online.

HER-2-positive metastatic breast cancer: new possibilities for therapy por E. V. Artamonova, L. V. Manzyuk

Connect to this object online.

Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors por E. V. Artamonova, E. I. Kovalenko

Connect to this object online.

Theoretical prerequisites and results of removal of primary tumor in patients with first detected stage IV breast cancer por Ye. V. Chernova, E. V. Artamonova, V. A. Khailenko, D. V. Komov

Connect to this object online.

CDK4/6 inhibitors in the treatment of metastatic breast cancer. Choosing optimal therapy for estrogen-receptor-positive HER2-negative metastatic breast cancer: analysis of doctors'... por E. V. Artamonova, E. I. Kovalenko, L. V. Bolotina, M. B. Stenina, R. V. Orlova, M. A. Mukhina

Connect to this object online.

Effectiveness of cyclin-dependent kinase 4 and 6 inhibitors for the treatment of hormonesensitive HER2-negative metastatic breast cancer in first-line therapy: A systematic literat... por N. A. Avxentyev, I. I. Andreyashkina, E. V. Artamonova, L. V. Bolotina, E. I. Kovalenko, N. N. Sisigina

Connect to this object online.

Clinical significance of changes in the expression level of markers of surrogate breast cancer subtypes in recurrent and metastatic foci (literature review) por Yu. S. Krumin, V. A. Khaylenko, N. A. Kozlov, G. Yu. Cheremis, A. V. Petrovskyy, D. V. Khaylenko, E. V. Artamonova, E. I. Kovalenko

Connect to this object online.

Microenvironment-related predictive markers of the therapeutic effectiveness of eribulin in patients with locally advanced or metastatic breast cancer: pilot study por L.  A. Tashireva, N. O. Popova, V. V. Alifanov, V. E.  Goldberg, E. I. Kovalenko, E. V. Artamonova, A. G.  Manikhas, D. M. Ponomarenko, N. V. Levchenko, E. I. Rossokha, S. Yu.  Krasilnikova, M. A. Zafirova, V. M.  Perelmuter

Connect to this object online.